Use Able AI chat for product recommendations

Recombinant Human TIMP2 protein (hFc Tag)

种属

Human

纯度

>90 %, SDS-PAGE

标签

hFc Tag

生物活性

未测试

Cat no : Eg0418

Print datasheet

Synonyms

TIMP2, TIMP-2, CSC 21K, CSC-21K, Metalloproteinase inhibitor 2



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Human TIMP2 protein Cys27-Pro220 (Accession# P16035) with a human IgG1 Fc tag at the C-terminus.
基因ID 7077
蛋白编号 P16035
预测分子量 47.8 kDa
SDS-PAGE 45-55 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

TIMP2, a 21-kDa protein, is a member of the family of matrix metalloproteinase inhibitors, which contains four members (TIMP1, TIMP2, TIMP3, and TIMP4). Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. TIMP-2 is the only TIMP functioning as both an MMP inhibitor and an activator, because it can interact with membrane type 1 MMP and pro-MMP2 to facilitate the activation of pro-MMP2 to its active form. TIMP2 can regulate many physiological progression such as tumor growth, metastasis, and angiogenesis through matrix metalloproteinases (MMPs). TIMP2 knockout resulted in constitutive MMP9 activation abundantly and adverse MI remodeling in vivo.

参考文献:

1. Stetler-StevensonWG.et al.(2008) Sci Signal.1(27):re6. 2. Hernandez-Barrantes S.et al. (2000).J Biol Chem.275(16):12080-9. 3. Seo DW.et al. (2003) Cell.114(2):171-80. 4. KandalamV.et al.(2010) Circ Res.106(4):796-808.

||
New chat

Able™

正在加载,请稍候...